Clare Market Investments’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,398
Closed -$298K 151
2023
Q4
$298K Sell
2,398
-1,977
-45% -$202K 0.1% 113
2023
Q3
$408K Sell
4,375
-9,695
-69% -$1.09M 0.16% 82
2023
Q2
$1.81M Buy
14,070
+7,849
+126% +$949K 0.67% 21
2023
Q1
$723K Buy
6,221
+618
+11% +$69.2K 0.3% 45
2022
Q4
$634K Buy
5,603
+2,225
+66% +$244K 0.3% 48
2022
Q3
$272K Buy
3,378
+692
+26% +$58.6K 0.12% 108
2022
Q2
$200K Sell
2,686
-1,398
-34% -$128K 0.09% 121
2022
Q1
$522K Buy
+4,084
New +$447K 0.17% 76

Other funds holding DXCM

Clare Market Investments's DXCM Position: Q1 2024 in Review

Clare Market Investments sold out of DexCom (DXCM) in Q1 2024, closing a stake of 2,398 shares — an estimated $298K sold.

Clare Market Investments first reported a position in DXCM in Q1 2022 and held it in 8 quarters. The position peaked at $1.81M in Q2 2023. 1,033 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

  • Clare Market Investments reported no remaining DexCom position as of Q1 2024 after selling out during the quarter.
  • Clare Market Investments sold 2,398 DexCom shares in Q1 2024, an estimated $298K.
  • Clare Market Investments first reported a position in DexCom in Q1 2022 and held it in 8 quarters.
  • Clare Market Investments's DexCom position peaked at $1.81M in Q2 2023.
  • 1,033 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Clare Market Investments's 13F filing for Q1 2024, filed 20 Feb 2025.